[#DIV28SUPER] Board of Scientific Affairs Callsfor Award Nominations

 

 

From: Wandersman, Suzanne
Sent: Monday, February 27, 2017 3:01 PM
Subject: Please Post on Division Listserv: Board of Scientific Affairs Callsfor Award Nominations
Importance: High

 

Hello:

 

I would appreciate you posting these links on your division's listserv. 

 

http://www.apa.org/science/about/psa/2017/01/meritorious-research-nominations.aspx

Meritorious Research Service Commendation: Call for Nominations, deadline is March 6, 2017

 

http://www.apa.org/science/about/psa/2017/01/distinguished-service-award.aspx

APA Distinguished Service Award: Nominate Your Colleague, deadline is April 3, 2017

 

http://www.apa.org/science/about/psa/2017/02/gold-medal-awards.aspx

2018 Gold Medal Awards for Life Achievement: Call for Nominations, deadline June 1, 2017

 

http://www.apa.org/science/about/psa/2017/02/distinguished-awards.aspx

Call for Nominations: 2018 APA Distinguished Scientific Awards, deadline June 1, 2017

 

Please share these calls for nominations with your colleagues.  We are trying to generate as many nominations as we can.  Thanks for your help.

 

 

 

Suzanne Wandersman

Director, Science Board and Committee Affairs

Science Directorate

American Psychological Association

750 First Street, NE

Washington, DC 20002-4242

(202) 336-6000

swandersman@apa.org

American Psychological Association www.apa.org   Advancing psychology to benefit society and improve people's lives

 

 

 

 

[#DIV28SUPER] Call for Papers - Special Issue on Ambulatory Assessment of Addictive Disorders

Addictive Behaviors - Call for Papers

Special Issue: Ambulatory Assessment of Addictive Disorders 

Addictive Behaviors is now accepting submissions for a special issue, Ambulatory Assessment of Addictive Disorders. Ambulatory assessment broadly refers to a number of remote monitoring techniques, including ecological momentary assessment (EMA), used to intensively study behavior in naturalistic settings. Submissions should utilize technology-based ambulatory assessment to enhance the study and treatment of addictive disorders. This may include substance use disorders and other addictive disorders (i.e., gambling disorder, internet addiction). Multimethod assessment approaches are particularly encouraged. Examples of potential topics include:

·         Identification of proximal risk factors for substance use or other addictive behaviors in real-world settings using ambulatory assessment/EMA

·         Continuous, physiological measurement of substance use using transdermal monitors

·         Detection or confirmation of substance use or other addictive behaviors in real-world settings

·         Mobile interventions for addictive disorders

·         Novel ambulatory methodologies for studying substance use and other addictive behaviors

·         Agreement between laboratory and ambulatory/EMA studies of addictive behaviors

·         Single-participant research designs using ambulatory assessment/EMA

Original research submissions, methodological papers, and review papers will be considered. Submissions may be focused on a variety of addictive behaviors (e.g., alcohol, tobacco, cannabis, opiate, cocaine, gambling, internet addiction) and in a variety of populations (e.g., adolescents, college students, older adults, underrepresented populations, individuals with comorbid psychopathology).

Successful papers will discuss how the results replicate, extend, or fail to replicate existing laboratory-based, cross-sectional, or epidemiological findings.

The deadline for manuscript submission is July 1, 2017 for consideration for inclusion in this special issue. All submissions must adhere to journal guidelines and will undergo peer review. Accepted papers will be published online individually prior to print publication. In order to be considered for this special issue, authors must select “SI: Ambulatory Assessment” from the “Choose Type of Article” drop down menu. Prior to submitting a manuscript, the authors are encouraged to submit a brief letter of intent to the Guest Editors, Rachel Tomko (Tomko@musc.edu) and Erin McClure (McCluree@musc.edu), to ensure that their topic fits within the scope of this special issue. 

 

----------------------

Erin A. McClure, Ph.D.

Assistant Professor

Addiction Sciences Division

Medical University of South Carolina

125 Doughty St., Suite 190, MSC 861

Charleston, SC  29425

Phone: 843-792-7192

Fax: 843-792-3982

 

 

Like us on Facebook and Follow us on Twitter!

[#DIV28SUPER] NIH Requests Information on Processes for database of Genotypes and Phenotypes (dbGAP) Data Submission, Access, and Management by April 7, 2017

 

NIH Requests Information on Processes for database of Genotypes and Phenotypes (dbGaP) Data Submission, Access, and Management

 

Today, in the NIH Guide to Grants and Contracts, NIH published a Request for Information (RFI) that seeks public comment on the data submission and access processes for the NIH National Center for Biotechnology (NCBI) database of Genotypes and Phenotypes (dbGaP).  The RFI also seeks comment on the management of data in dbGaP in order to consider options to improve and streamline these processes and to maximize the use and utility of dbGaP.

 

The complete RFI, as well as instructions on how to comment, can be found by clicking here.  Electronic responses will be accepted through April 7, 2017. NIH will consider all public comments before taking next steps. No proprietary, classified, confidential, or sensitive information should be included in your response. Comments received, including any personal information, will be posted without change after the close of the comment period to the following website: https://gds.nih.gov/

 

Comments may also be mailed to: Office of Science Policy, National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892. Mailed comments must be postmarked by April 7, 2017, to be considered.

 

Additional information about the importance of this RFI can be found in an “Under the Poliscope” blog published today by Dr. Carrie D. Wolinetz.

 

For more information or additional questions, please contact the NIH Office of Science Policy, by email at SciencePolicy@od.nih.gov or by telephone at 301-496-9838.

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

 

[#DIV28SUPER] The latest from NIDA Advisory Council

Dear Colleagues:

As promised, here’s the latest from Wednesday's meeting of the NIDA Advisory Council (the linked Power Points will take a few moments to download).

 

What did Dr. Volkow report to NIDA Council?

What are Dr. Josh Gordon’s priorities now that he has assumed the Directorship of NIMH?

Want an update on NIDA’s Marijuana Policy Research Program?

Best,

-geoff

 

 

Geoffrey K. Mumford, Ph.D| Associate Executive Director for Government Relations Science Directorate | 202.336.6067 | gmumford@apa.org  American Psychological Association www.apa.org   Advancing psychology to benefit society and improve people’s lives

 

[#DIV28SUPER] The latest from NIAAA Advisory Council

Dear Colleagues:

Here’s the latest from yesterday's meeting of the NIAAA Advisory Council (the linked Power Points will take a few moments to download).  NIDA Advisory Council is next week so stay tuned for those presentations or grab some popcorn and watch the webcast on your own starting at 10:45 on 2/15.

 

What did Dr. Koob report to NIAAA Council?

Looking for an update on where NIAAA is going next with alcohol and PTSD comorbidity research?

Want to see how neuroimaging in alcoholism translates from animals to humans?

Want to learn about alcohol and stress mechanisms from risk to relapse and recovery?

Care to read about VA research?

Interested in learning how NIMH is making data available to the research community?

Until next week,

Best,

-geoff

 

 

Geoffrey K. Mumford, Ph.D| Associate Executive Director for Government Relations Science Directorate | 202.336.6067 | gmumford@apa.org  American Psychological Association www.apa.org   Advancing psychology to benefit society and improve people’s lives

 

 

[#DIV28SUPER] MU-ARTSS Undergraduate Summer Research Opportunity

Colleagues and Friends,

 

I want to make you aware of a paid summer research opportunity for undergraduates that we have at the University of Missouri. We sent out announcements late in the fall but we wanted to bring this opportunity to the attention of those who might have missed our earlier announcement (and remind those who received it at, perhaps, an suboptimal time).  With the application deadline quickly approaching we wanted to alert colleagues who know of motivated undergraduates who might be interested.

 

We offer a 9 week program with a stipend of $3,600 and provide room and board as well.  We have an intensive week-long didactic program followed by an 8-week internship in one of our research labs of faculty members in the Department of Psychological Sciences involved in alcohol and addiction research. We are particularly interested in recruiting underrepresented minority students who are interested in psychological research on alcohol use, alcohol use disorder, and addiction but all motivated talented and interested undergraduates are encouraged to apply.  This will be the second year of our MU Alcohol Research Training Summer School, MU-ARTSS and, by all accounts, our first year was a great success. We hope to build upon this success in the coming year.

 

Applications and additional information can be found at:  

http://alcoholresearch.missouri.edu/relatedtraining.html

 

Applications are due February 15^th.  I realize this deadline is rapidly approaching but we’d like to reach as many potential applicants as possible.

 

Kenneth J. Sher, Ph.D.

Curators’ Professor of Psychological Sciences

University of Missouri

210 McAlester Hall

Columbia, MO 65211

Tel: 573-882-4279

Email: sherk@missouri.edu

Web: http://faculty.missouri.edu/sherk/index.htm

 

[#DIV28SUPER] UCSF LEAD Program

Training Opportunity for Underrepresented Early-Career Addictions Researchers

 

APPLICATION DEADLINE EXTENDED TO FEBRUARY 28^th, 2017

 

We are happy to announce that the Learning for Early Careers in Addiction and Diversity (LEAD) Program is recruiting its new cohort!

The LEAD Program is an NIH-sponsored R25 training program that uses the NIDA CTN as a platform for providing research training to early-career investigators from underrepresented racial/ethnic minority groups conducting research in the substance use disorder (SUD) treatment and services field. This 2-year training program is based at the University of California, San Francisco (UCSF). Program scholars will spend 4 weeks at UCSF each summer and will develop and execute a pilot study at their home institution throughout the academic year. The program provides travel and housing funds as well as up to $25,000 to conduct the pilot study, which will serve as foundational data to support the submission of an R or K application. The program is directed by Carmen Masson, PhD, and James Sorensen, PhD, at UCSF.

 

The program recruitment flyer containing further information on eligibility criteria and selection process is attached. The deadline for applications is now February 28^th, 2017. For any questions or to nominate a qualified candidate, please contact Rebecca Cook at rebecca.cook@ucsf.edu. Additional information can be found at http://psych.ucsf.edu/lead/.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] UVM NIH POSTDOCTORAL RESEARCH FELLOWSHIP POSITION

NIH Postdoctoral Research Fellowship Opportunity

 

The University of Vermont’s Center on Behavior and Health (VCBH) announces NIH postdoctoral research fellowship opportunities in our internationally recognized center of excellence for the study of substance abuse. 

Eligibility: Applicants must have completed their training in psychology, behavior analysis, or a related discipline and be U.S. citizens or permanent residents. Trainees are selected on the basis of scholastic record and commitment to a career in substance abuse research. Individuals must be highly motivated, possess initiative and a desire to learn and expand their interests and expertise.

 

 Appointment:  2-3 yrs.

 

 Benefits: Stipend, medical insurance coverage, and travel funds supported by NIH Institutional Training Awards.

 

To apply: Send application form (downloaded from VCBH website), a cover letter, curriculum vitae, statement of research interests, and 3 letters of reference to:  Dr. Stephen Higgins c/o Ms. Marissa Wells (mwells2@uvm.edu).

 

About us: The VCBH was established in 2013, sponsored in part by a Centers of Biomedical Research Excellence (COBRE) Award from the National Institute on General Medical Sciences and a Centers of Tobacco Regulatory Science (TCORS) Award from the National Institute on Drug Abuse. The VCBH resides within the College of Medicine at the University of Vermont, with the director and administrative offices being located within the Department of Psychiatry, and participating investigators, collaborators, and advisors across 15 academic departments in the College of Medicine and 7 colleges within the University of Vermont and 5 other universities. The VCBH is further strengthened by interdisciplinary collaborations with key community healthcare leaders and distinguished scientific advisory panels. The focus of the VCBH is on investigating relationships between personal behaviors and risk for chronic disease and premature death, with a specific focus on understanding mechanisms underpinning risk, and developing effective interventions and policies to promote healthy behavior.

 

 For more information:  Contact Ms. Marissa Wells at mwells2@uvm.edu or see our website.

 

 

 Burlington, Vermont is located in the beautiful Lake Champlain region, surrounded by the Green and Adirondack Mountains. It is a great place for families, boasting excellent schools and year-round recreational opportunities. It is home to the University of Vermont and many other colleges that provide an academically stimulating and culturally rich environment. Montreal and Boston are within easy driving distances.

--

Stephen T. Higgins, Ph.D.

Director, Vermont Center on Behavior and Health

Virginia H. Donaldson Professor of Translational Science

Departments of Psychiatry and Psychology

Vice Chair, Department of Psychiatry

University of Vermont

1 South Prospect Street

Burlington, VT  05401-1419

VCBH Administrator: Marissa Wells
mwells2@uvm.edu

802-656-0079

[#DIV28SUPER] Briefing on Synthetic Opioids: the Science, Pharmacology, & Public Health Challenges

Dear Colleagues,

The Bipartisan Heroin Task Force Chaired by Rep. Tom MacArthur (R-NJ) and Rep. Ann McLane Kuster (D-NH) will be holding a briefing on Monday, February 6^th at 4:00.  Dr. Lisa Marsch has been invited to present data from her NIDA-funded Fentanyl Hot Spot Study and the briefing will be broadcast live on CSPAN so please consider tuning in to virtually cheer Lisa on.  Other presenters include Dr. Nora Volkow, Director of the National Institute on Drug Abuse, Dr. Corey Waller, Legislative Advocacy Committee Chairman of the American Society of Addiction Medicine and Dr. Josh Rising, Director of Health Programs for the Pew Charitable Trusts.

 

Regards,

-geoff

 

Geoffrey K. Mumford, Ph.D| Associate Executive Director for Government Relations Science Directorate | 202.336.6067 | gmumford@apa.org  American Psychological Association www.apa.org   Advancing psychology to benefit society and improve people’s lives